Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Nausea
ADR ID BADD_A02979
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.07      Nausea and vomiting symptoms
07.01.07.001      Nausea
Description A disorder characterized by a queasy sensation and/or the urge to vomit. [CTCAE] An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses. [MeSH]
MedDRA Code 10028813
MeSH ID D009325
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Churning of stomach | Feeling queasy | Nausea | Nausea alone | Nauseated | Nauseous | Queasy | Sickness/nausea | Nausea aggravated | Nausea post chemotherapy | Postprandial nausea | Nausea post radiotherapy | Anticipatory nausea
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
5-hydroxytryptamine receptor 2AP28223T32060
5-hydroxytryptamine receptor 2BP41595T31204
5-hydroxytryptamine receptor 3AP46098T64591
AcetylcholinesteraseP22303T30082
Alpha-1A adrenergic receptorP35348T92609
Histamine H1 receptorP35367T77913
Muscarinic acetylcholine receptor M1P11229T28893
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02496Elagolix0.088212%
BADD_D02497Avatrombopag0.005445%
BADD_D02498Abemaciclib0.024510%
BADD_D02499Fostamatinib0.002178%
BADD_D02500Alpelisib0.009857%
BADD_D02503Telotristat ethyl-
BADD_D02504Lorlatinib--
BADD_D02507Deutetrabenazine0.018300%
BADD_D02508Edaravone--
BADD_D02509Brigatinib0.004529%
BADD_D02510Rucaparib0.204071%
BADD_D02511Siponimod0.014475%
BADD_D02512Secnidazole0.002192%
BADD_D02514Etelcalcetide0.207215%
BADD_D02515Pexidartinib0.003463%
BADD_D02516Plecanatide0.003660%
BADD_D02517Enasidenib0.005861%
BADD_D02518Semaglutide0.115452%
BADD_D02520Baloxavir marboxil--
BADD_D02521Sodium zirconium cyclosilicate--
BADD_D02522Lithium citrate--
BADD_D02523Hydrocortisone succinate0.014354%
BADD_D02524Ivosidenib0.002131%
BADD_D02526Larotrectinib0.001598%
The 69th Page    First    Pre   69    Total 69 Pages